SALT LAKE CITY – Could a pharmaceutical grade cannabis help treat young women with severe epilepsy? That’s what researchers at the University of Utah and Primary Children’s Hospital have been looking into the past two years.
“Most of the patients we treat have already been on trials of over 5 usually more than 10 seizure medications or other treatments. Those have been unsuccessful,” said Dr. Francis Filloux, who is overseeing the clinical trials.
Young patients have been taking Epidiolex, a liquid form of Cannabidiol.
Researchers say early clinical results are promising with patients reporting a 40 percent decrease in the amount and severity of seizures.
“There have been mild side effects most of them have been tolerable. For example, children have had diarrhea because of the oil the substance is dissolved in some have been more tired, some changes in appetite,” Filloux said.
Johanne Holme’s son Porter is participating in the clinical trials.
“Eight weeks after he